Targeting connexin 43 prevents platelet-derived growth factor-BB-induced phenotypic change in porcine coronary artery smooth muscle cells. 2008

Christos E Chadjichristos, and Sandrine Morel, and Jean-Paul Derouette, and Esther Sutter, and Isabelle Roth, and Anne C Brisset, and Marie-Luce Bochaton-Piallat, and Brenda R Kwak
Division of Cardiology, Geneva University Hospitals, Faculty of Medicine, University of Geneva, Switzerland.

We previously reported that reducing the expression of the gap junction protein connexin (Cx)43 in mice restricts intimal thickening formation after acute vascular injury by limiting the inflammatory response and the proliferation and migration of smooth muscle cells (SMCs) toward the damaged site. SMC populations isolated from porcine coronary artery exhibit distinct phenotypes: spindle-shaped (S) and rhomboid (R). S-SMCs are predominant in the normal media, whereas R-SMCs are recovered in higher proportion from stent-induced intimal thickening, suggesting that they participate in the restenotic process. Here, we further investigate the relationship between connexin expression and SMC phenotypes using porcine coronary artery SMCs. Cx40 was highly expressed in normal media of porcine coronary artery in vivo, whereas Cx43 was barely detectable. In contrast, Cx40 was downregulated and Cx43 was markedly upregulated in stent-induced intimal thickening. In vitro, S-SMCs expressed Cx40 and Cx43. In R-SMCs, Cx43 expression was increased and Cx40 was absent. We confirmed that S-SMCs treated with platelet-derived growth factor-BB acquire an R phenotype. This was accompanied by an upregulation of Cx43 and a loss of Cx40. Importantly, platelet-derived growth factor-BB-induced S-to-R phenotypic change was prevented by a reduction of Cx43 expression with antisense, ie, S-SMCs retained their typical elongated appearance and the expression of alpha-smooth muscle actin, a well-known SMC differentiation marker, whereas the expression of S100A4, a typical marker of R-SMCs, was prevented. In conclusion, limiting Cx43 expression in S-SMCs prevents platelet-derived growth factor-BB-induced S-to-R modulation. This suggests that Cx43 may be an additional target for local delivery strategies aimed at reducing restenosis.

UI MeSH Term Description Entries
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D009418 S100 Proteins A family of highly acidic calcium-binding proteins found in large concentration in the brain and believed to be glial in origin. They are also found in other organs in the body. They have in common the EF-hand motif (EF HAND MOTIFS) found on a number of calcium binding proteins. The name of this family derives from the property of being soluble in a 100% saturated ammonium sulfate solution. Antigen S 100,Nerve Tissue Protein S 100,S100 Protein,S-100 Protein,S100 Protein Family,Protein, S100,S 100 Protein
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D010982 Platelet-Derived Growth Factor Mitogenic peptide growth hormone carried in the alpha-granules of platelets. It is released when platelets adhere to traumatized tissues. Connective tissue cells near the traumatized region respond by initiating the process of replication. Platelet Derived Growth Factor,Factor, Platelet-Derived Growth,Growth Factor, Platelet-Derived
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003331 Coronary Vessels The veins and arteries of the HEART. Coronary Arteries,Sinus Node Artery,Coronary Veins,Arteries, Coronary,Arteries, Sinus Node,Artery, Coronary,Artery, Sinus Node,Coronary Artery,Coronary Vein,Coronary Vessel,Sinus Node Arteries,Vein, Coronary,Veins, Coronary,Vessel, Coronary,Vessels, Coronary

Related Publications

Christos E Chadjichristos, and Sandrine Morel, and Jean-Paul Derouette, and Esther Sutter, and Isabelle Roth, and Anne C Brisset, and Marie-Luce Bochaton-Piallat, and Brenda R Kwak
June 2018, Molecular medicine reports,
Christos E Chadjichristos, and Sandrine Morel, and Jean-Paul Derouette, and Esther Sutter, and Isabelle Roth, and Anne C Brisset, and Marie-Luce Bochaton-Piallat, and Brenda R Kwak
July 2016, Molecular medicine reports,
Christos E Chadjichristos, and Sandrine Morel, and Jean-Paul Derouette, and Esther Sutter, and Isabelle Roth, and Anne C Brisset, and Marie-Luce Bochaton-Piallat, and Brenda R Kwak
January 2013, International journal of urology : official journal of the Japanese Urological Association,
Christos E Chadjichristos, and Sandrine Morel, and Jean-Paul Derouette, and Esther Sutter, and Isabelle Roth, and Anne C Brisset, and Marie-Luce Bochaton-Piallat, and Brenda R Kwak
November 1996, Journal of cellular physiology,
Christos E Chadjichristos, and Sandrine Morel, and Jean-Paul Derouette, and Esther Sutter, and Isabelle Roth, and Anne C Brisset, and Marie-Luce Bochaton-Piallat, and Brenda R Kwak
August 2014, Molecular medicine reports,
Christos E Chadjichristos, and Sandrine Morel, and Jean-Paul Derouette, and Esther Sutter, and Isabelle Roth, and Anne C Brisset, and Marie-Luce Bochaton-Piallat, and Brenda R Kwak
October 2014, Nutrition research and practice,
Christos E Chadjichristos, and Sandrine Morel, and Jean-Paul Derouette, and Esther Sutter, and Isabelle Roth, and Anne C Brisset, and Marie-Luce Bochaton-Piallat, and Brenda R Kwak
July 2015, Zhonghua nan ke xue = National journal of andrology,
Christos E Chadjichristos, and Sandrine Morel, and Jean-Paul Derouette, and Esther Sutter, and Isabelle Roth, and Anne C Brisset, and Marie-Luce Bochaton-Piallat, and Brenda R Kwak
December 1992, Circulation research,
Christos E Chadjichristos, and Sandrine Morel, and Jean-Paul Derouette, and Esther Sutter, and Isabelle Roth, and Anne C Brisset, and Marie-Luce Bochaton-Piallat, and Brenda R Kwak
March 1999, In vitro cellular & developmental biology. Animal,
Christos E Chadjichristos, and Sandrine Morel, and Jean-Paul Derouette, and Esther Sutter, and Isabelle Roth, and Anne C Brisset, and Marie-Luce Bochaton-Piallat, and Brenda R Kwak
January 2016, Molecular medicine reports,
Copied contents to your clipboard!